Interleukin 18 (IL18) gene promoter polymorphisms are associated with type 1 diabetes mellitus in Brazilian patients

Cytokine

Volumn 62, Issue 2, 2013, Pages 286-289

  Tavares, Nathália A C ^a   Santos, Manuella M S ^a   Moura, Ronald ^a   Araújo, Jacqueline ^a   Guimarães, Rafael ^a   Crovella, Sergio ^a   Brandão, Lucas ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Association study; Autoimmune thyroiditis; Celiac disease; IL18; Type 1 diabetes

Indexed keywords

INTERLEUKIN 18;

ADOLESCENT; ALLELE; ARTICLE; AUTOIMMUNE THYROIDITIS; BRAZIL; CELIAC DISEASE; CHILD; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERLEUKIN 18 GENE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; COMPLICATION; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MALE; ONSET AGE;

AGE OF ONSET; BRAZIL; CELIAC DISEASE; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-18; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; THYROIDITIS, AUTOIMMUNE;

EID: 84876811529     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.03.004     Document Type: Article

References (25)

1. Abiru N., Kawasaki E., Eguch K. Current knowledge of Japanese type 1 diabetic syndrome. Diabetes Metab Res Rev 2002, 18:357-366.
2. Pham-Short A., Donaghue K.C., Ambler G., Chan A.K., Craig M.E. Coeliac disease in Type 1 diabetes from 1990 to 2009: higher incidence in young children after longer diabetes duration. Diabetes Med 2012, 29:286-289.
3. Smyth D.J., Plagnol V., Walker N.M., Cooper J.D., Downes K., Yang J.H., et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008, 359:2767-2777.
4. Larizza D., Calcaterra V., Klersy C., Badulli C., Caramagna C., Ricci A., et al. Common immunogenetic profile in children with multiple autoimmune diseases: the signature of HLA-DQ pleiotropic genes. Autoimmunity 2012, 45:470-475.
5. Baumann B., Salem H.H., Boehm B.O. Anti-inflammatory therapy in type 1 diabetes. Curr Diab Rep 2012, 12:499-509.
6. Hulme M.A., Wasserfall C.H., Atkinson M.A., Brusko T.M. Central role for interleukin-2 in type 1 diabetes. Diabetes 2012, 61:14-22.
7. Kunz M., Ibrahim S.M. Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm 2009, 979258-979278.
8. Reddy P. Interleukin-18: recent advances. Curr Opin Hematol 2004, 11:405-410.
9. Novick D., Kim S.H., Fantuzzi G., Reznikov L.L., Dinarello C.A., Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999, 10:127-136.
10. Giedraitis V., He B., Huang W.X., Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001, 112:146-152.
11. Kretowski A., Mironczuk K., Karpinska A., Bojaryn U., Kinalski M., Puchalski Z., et al. Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes 2002, 51:3347-3349.
12. Dong G.P., Yu Z.S., Liang L., Zou C.C., Fu J.F., Wang C.L. IL-18 gene promoter -137C/G and -607C/A polymorphisms in Chinese Han children with type 1 diabetes mellitus. Int J Immunogenet 2007, 34:75-79.
13. Ide A., Kawasaki E., Abiru N., Sun F., Kobayashi M., Fukushima T., et al. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J Autoimmun 2004, 22:73-78.
14. Association A.D. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006, 29(Suppl 1):S43-S48.
15. Cebeci A.N., Nuhoglu Y., Arslanoglu I., Erguven M., Agachan N. The role of IL-18 in Th1/Th2 balance in children. Allergy Asthma Proc 2006, 27:365-370.
16. Rachmiel M., Bloch O., Bistritzer T., Weintrob N., Ofan R., Koren-Morag N., et al. TH1/TH2 cytokine balance in patients with both type 1 diabetes mellitus and asthma. Cytokine 2006, 34:170-176.
17. Nicoletti F., Conget I., Di Marco R., Speciale A.M., Morinigo R., Bendtzen K., et al. Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes. Diabetologia 2001, 44:309-311.
18. Giedraitis V., He B., Hillert J. Mutation screening of the interferon-gamma gene as a candidate gene for multiple sclerosis. Eur J Immunogenet 1999, 26:257-259.
19. Rachmiel M., Bloch O., Shaul A.A., Ben-Yehudah G., Bistritzer Z., Weintrob N., et al. Young patients with both type 1 diabetes mellitus and asthma have a unique IL-12 and IL-18 secretory pattern. Pediatr Diabetes 2011, 12:596-603.
20. Marleau A.M., Sarvetnick N.E. IL-18 is required for self-reactive T cell expansion in NOD mice. J Autoimmun 2011, 36:263-277.
21. Martin R.J., Savage D.A., Carson D.J., Maxwell A.P., Patterson C.C. Interleukin 18 promoter polymorphisms are not strongly associated with type I diabetes in a UK population. Genes Immun 2005, 6:171-174.
22. Mojtahedi Z., Naeimi S., Farjadian S., Omrani G.R., Ghaderi A. Association of IL-18 promoter polymorphisms with predisposition to Type 1 diabetes. Diabet Med 2006, 23:235-239.
23. Novota P., Kolostova K., Pinterova D., Novak J., Treslova L., Andel M., et al. Interleukin IL-18 gene promoter polymorphisms in adult patients with type 1 diabetes mellitus and latent autoimmune diabetes in adults. Immunol Lett 2005, 96:247-251.
24. Szeszko J.S., Howson J.M., Cooper J.D., Walker N.M., Twells R.C., Stevens H.E., et al. Analysis of polymorphisms of the interleukin-18 gene in type 1 diabetes and Hardy-Weinberg equilibrium testing. Diabetes 2006, 55:559-562.
25. Pan H.F., Leng R.X., Ye D.Q. Lack of association of interleukin-18 gene promoter -607 A/C polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Lupus 2011, 20:945-951.